SIOP Europe, the European Society for Paediatric Oncology (SIOPE) shared a post on LinkedIn:
“In the EU, half of the neuroblastoma patients are diagnosed with high-risk disease and face frequent recurrences.
The MONALISA EUProject is paving the way for a less invasive, accessible tool for monitoring relapsed neuroblastoma.
On International Neuroblastoma Awareness day, let us celebrate the innovation that brings improvements in survivorship for neuroblastoma patients.
Learn more about the EUProject here.”
More from SIOPE on OncoDaily.